Myositis due to Sorafenib intake in a patient with hepatocellular carcinoma

Dig Liver Dis. 2011 Apr;43(4):333-4. doi: 10.1016/j.dld.2010.11.009. Epub 2011 Jan 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Benzenesulfonates / adverse effects*
  • Benzenesulfonates / therapeutic use
  • Carcinoma, Hepatocellular / drug therapy*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Myositis / chemically induced*
  • Myositis / pathology
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib